Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma
May 07, 2018 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, May 07, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference
May 04, 2018 09:29 ET
|
Delcath Systems, Inc.
NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Announces Another DSMB Recommendation for Phase 3 Focus Trial
May 03, 2018 08:30 ET
|
Delcath Systems, Inc.
NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Announces Ratio for Reverse Split Authorization
May 01, 2018 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the...
Delcath Announces Shareholder Approval of Consent Solicitation
April 09, 2018 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath’s PHP Therapy to be Featured in Video Training Session at European Conference of Interventional Oncology
April 03, 2018 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Summary of Recent Published Research on Delcath’s PHP Therapy Presented at Society of Surgical Oncology Annual Symposia
March 29, 2018 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that a...
Delcath to Present at Oppenheimer 28th Annual Healthcare Conference
March 19, 2018 16:05 ET
|
Delcath Systems, Inc.
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Announces 2017 Financial Results
March 16, 2018 09:00 ET
|
Delcath Systems, Inc.
NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces...
Delcath to Present at 30th Annual Roth Conference
March 12, 2018 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, March 12, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that...